Wednesday, August 14, 2019

Gateway Biotechnology Chosen to Participate in an Accelerator Program

Group of people in a meeting
Photo by Austin Distel on Unsplash
With over two decades of experience in the fields of plant genomics and developmental biology, Dr. Thomas Brutnell serves as the vice president of Gateway Biotechnology in St. Louis, Missouri. In this role, Dr. Thomas Brutnell oversees the product development of repurposed FDA-approved drugs and new drug candidates to prevent and treat noise-induced hearing loss.

Gateway Biotechnology was chosen to join the MassChallenge Boston, a zero-equity, competition-based accelerator program that offers an opportunity for startups to win more than $1 million in cash prizes. 

Founded in Boston, Massachusetts, in 2009, MassChallenge supports startups with the highest potential to make a positive impact across all industries worldwide. In March 2019, MassChallenge chose more than 100 startups with focuses ranging from health care and life sciences to high tech, consumer goods, cleantech, and social impact to participate in the accelerator program.

In addition to winning cash prizes, startups will also gain access to expert mentorship, networking with corporate partners, and spacious co-working spaces at the Innovation and Design Building in Boston. During the program, the participants will partake in an evidence-based curriculum that tackles the essential stages of product development.